1. Public Affairs and Policy Department; Mitsubishi Tanabe Pharma Corporation; Tokyo Japan
2. Institute for Health Economics and Policy; Minato-ku Tokyo Japan
3. Laboratory of Pharmaceutical Regulatory Science; Graduate School of Pharmaceutical Sciences; The University of Tokyo; Tokyo Japan